Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues.
Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses.
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Investigating Tissue Optical Properties and Texture Descriptors of the Retina in Patients with Multiple Sclerosis.
Disability profile of multiple sclerosis in New Zealand.
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis.
Autopsy-proven demyelination associated with infliximab treatment.
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
New pharmacological approaches against chronic bowel and bladder problems in paralytics.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Editorial: Glial Cells: Managers of Neuro-Immunity.
A Novel Asp121Asn Mutation of Myelin Protein Zero Is Associated with Late-Onset Axonal Charcot-Marie-Tooth Disease, Hearing Loss and Pupil Abnormalities.
Patient-specific early classification of multivariate observations.
Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis.
Evidence for the Importance of Vitamin D Status in Neurologic Conditions.
Omega-3 prevents myelin degeneration in rat foetuses exposed to radiation.
Response to Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature.
Volumetric Examination of MS Plaques and Correlation with EDSS Ratings.
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis.
12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis.
Hypothalamic abnormality in patients with inflammatory demyelinating disorders.

Pages